TRIDENT LIFELINE
|
The Current P/S Ratio of TRIDENT LIFELINE is 5.98.
Share Price | ₹169.0 | May 18,2024 |
Market Cap | ₹194.4 Cr | |
Sales-TTM | ₹32.5 Cr | TTM-Consolidated Results |
Price/Sales | 5.98x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of TRIDENT LIFELINE
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹194.4 Cr] as on May 18,2024
(/) Sales [ ₹32.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 5.98x ]
Thus, for TRIDENT LIFELINE , the investors are currently willing to pay '5.98 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of TRIDENT LIFELINE !
The chart below summarizes the trend in P/S Ratio of TRIDENT LIFELINE over the last five years.
Historical PS (Price/Sales) ratio chart of TRIDENT LIFELINE
PS Ratio Performance Analysis for TRIDENT LIFELINE
- TRIDENT LIFELINE 's p/e ratio for fiscal years ending Mar2023 to Mar2022 averaged 2.89x.
- TRIDENT LIFELINE 's operated at median p/e ratio of 5.77x from fiscal years ending March 2018 to 2022.
- Looking back at the last 2 fiscal years, TRIDENT LIFELINE 's p/e ratio peaked in Mar2023 at 5.77x.
- TRIDENT LIFELINE 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does TRIDENT LIFELINE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
TRIDENT LIFELINE | 32.5 | 5.98 | 194.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 47,444.6 | 7.74 | 367,290.0 |
CIPLA LTD | 25,774.1 | 4.40 | 113,357.0 |
DR REDDYS LABORATORIES LTD | 28,011.1 | 3.46 | 97,001.5 |
ZYDUS LIFESCIENCES LTD | 19,547.4 | 5.69 | 111,134.0 |
DIVIS LABORATORIES LTD | 7,492.8 | 13.91 | 104,235.0 |
MANKIND PHARMA LTD | 10,334.8 | 8.19 | 84,596.1 |
TORRENT PHARMACEUTICALS LTD | 10,474.0 | 8.74 | 91,556.3 |
LUPIN LTD | 20,010.8 | 3.78 | 75,652.2 |
AUROBINDO PHARMA LTD | 27,894.7 | 2.53 | 70,467.9 |
ABBOTT INDIA LTD | 5,848.9 | 9.68 | 56,616.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs TRIDENT LIFELINE 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.53x |
Max industry PS | 13.91x |
Median industry PS | 5.98x |
Average industry PS | 6.74x |
You may also like the below Video Courses